rfhg_5146.1

Basic information about the TSS

---

TSS ID: rfhg_5146.1 TSS ID(Version3): hg_2164.1 hg_2163.1 Species: human Chr: chr1		Start: 36224274 End: 36224493 Strand: +
Source datasets	FANTOM5|EPD|DBTSS|DRA000914|ENCODE|PRJDB5282|PRJNA4843412 |DRA013844|PRJNA548673|PRJNA401781|PRJNA615891|PRJNA597322
Protocol	CAGE|TSS_database|TSS-seq|C1CAGE|NETCAGE|RAMPAGE |oligo_capping|ReCappable-seq|SLIC_CAGE|TIF-seq2|STRIPE-seq
TSS cluster detected*	16

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D2151367,EH38E1337317)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000469141.6:0 ENST00000648638.1:0 ENST00000354618.10:0 BC065519:0 BC010997:0 BC002501:0 AF117756:0 BC019076:0 BC112330:0 BC112350:0 GeneID: 9967 HGNC/MGI_ID: HGNC:22964 UniProt_ID: A0A3B3ITZ9 Q05D20 Q6P0P7 Q9Y2W1 Nearer transcript ids and distances:

Gene_name: thyroid hormone receptor associated protein 3 Gene_symbol: THRAP3 Gene_synonyms: BCLAF2 TRAP150 Gene_source: HGNC:22964

TATA-Box annotation

---

Distance to TSS:	-60
Nearest PromoterID:	NM_005119
Entrez ID:	9967
Nearest Unigene:	Hs.744057
Nearest Refseq:	NM_005119
Nearest Ensembl:	ENSG00000054118
Gene Name:	thyroid hormone receptor associated protein 3
Gene Alias:	BCLAF2|TRAP150
Gene Type:	protein-coding
CpG%:	0.114155
GC%:	0.659091
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@THRAP3 p2@THRAP3 p3@THRAP3 p4@THRAP3
Sample		p1@THRAP3	p2@THRAP3	p3@THRAP3	p4@THRAP3
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	45.97	2.73	6.23	0.19
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	44.31	2.02	5.46	0.40
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	46.88	1.74	6.56	0.77
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	33.47	1.46	5.20	0.21
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	43.87	2.92	7.42	0.67
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	39.15	2.52	5.43	0.97
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	56.65	3.27	5.23	1.09
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	56.19	4.12	7.02	1.21
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	48.30	4.27	3.21	0.21
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	38.26	5.80	5.22	2.32
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	44.06	5.66	6.47	3.23
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	49.19	4.07	2.85	2.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	42.55	1.13	1.45	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	39.54	0.75	0.90	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	43.91	1.54	0.88	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	32.44	0.50	0.75	0.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	37.35	0.66	0.44	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	33.75	1.27	0.84	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	37.32	1.07	3.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	33.40	0.60	0.15	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	39.69	0.80	0.27	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	35.91	0.52	0.17	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	35.55	1.42	0.26	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	34.22	0.00	0.49	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	36.63	0.77	0.26	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	31.02	0.63	0.32	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	32.42	1.65	1.65	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	42.44	0.94	0.94	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	35.86	0.97	0.16	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	39.63	0.90	1.09	0.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	34.54	0.84	1.67	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	32.04	0.39	0.39	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	34.19	0.63	0.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	54.27	0.82	0.66	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	35.72	0.37	0.93	0.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	35.45	0.57	0.77	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	37.81	1.84	1.02	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	35.86	0.81	0.40	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	39.98	1.62	1.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	39.61	0.72	1.20	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	37.64	0.94	0.94	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	46.11	1.17	0.59	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	39.65	0.63	1.05	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	34.62	0.52	0.00	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	48.79	0.60	0.60	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	41.64	0.93	1.63	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	37.43	0.24	0.48	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	43.52	0.30	1.79	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	35.91	0.96	0.96	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	44.69	2.22	1.01	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	45.70	1.23	1.23	1.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	44.47	0.89	2.22	0.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	251.86	0.00	181.90	13.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	36.20	0.71	0.35	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	30.16	1.33	0.66	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	120.81	0.00	10.07	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	63.83	1.38	1.84	0.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	35.65	1.94	1.94	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	33.08	0.32	1.61	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	64.12	0.94	2.83	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	35.25	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	37.01	0.56	2.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	87.58	0.80	7.17	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	42.47	1.02	1.36	0.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	33.79	1.30	0.97	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	30.88	0.35	1.06	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	226.30	0.00	193.97	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	189.54	0.00	102.67	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	24.86	0.98	0.98	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	26.28	0.99	0.50	1.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	24.86	0.94	0.47	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	45.37	0.99	0.66	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	32.79	1.24	0.62	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	31.80	0.31	0.61	0.00
Adipocyte - breast, donor1	11376-118A8	48.94	0.63	1.11	1.27
Adipocyte - breast, donor2	11327-117E4	31.60	0.32	1.12	0.48
Adipocyte - omental, donor1	11473-119C6	44.53	1.15	0.89	1.27
Adipocyte - omental, donor2	11474-119C7	27.66	0.75	0.75	0.00
Adipocyte - omental, donor3	11475-119C8	23.44	0.67	0.67	0.33
Adipocyte - perirenal, donor1	11476-119C9	29.35	0.00	1.28	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	13.19	0.00	1.10	1.10
Adipocyte - subcutaneous, donor2	11336-117F4	43.81	0.00	0.90	2.26
Adipocyte - subcutaneous, donor3	11408-118E4	25.37	0.00	0.35	1.56
Adipocyte differentiation, day04, donor1	13019-139D4	78.03	1.17	0.39	0.39
Adipocyte differentiation, day04, donor2	13022-139D7	37.32	0.77	0.26	0.51
Adipocyte differentiation, day04, donor3	13025-139E1	47.67	0.28	0.56	0.84
Adipocyte differentiation, day04, donor4	13028-139E4	42.91	0.59	1.18	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	70.38	1.29	1.29	0.56
Adipocyte differentiation, day08, donor2	13023-139D8	48.74	2.26	2.90	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	48.52	1.07	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	44.51	0.00	0.56	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	38.68	1.25	0.83	0.83
Adipocyte differentiation, day12, donor2	13024-139D9	42.20	0.50	1.76	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	32.07	0.33	0.33	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	33.80	0.61	0.91	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	37.13	0.66	0.66	0.22
Alveolar Epithelial Cells, donor2	11590-120G6	9.68	0.36	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	9.58	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	38.14	1.80	1.26	0.18
Amniotic Epithelial Cells, donor2	11613-122A2	11.71	1.67	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	31.43	1.23	0.62	0.00
Anulus Pulposus Cell, donor1	11248-116E6	65.11	1.14	2.29	2.63
Anulus Pulposus Cell, donor2	11463-119B5	35.51	0.24	0.98	0.49
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	27.41	0.45	5.39	0.90
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	31.26	2.17	2.60	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	21.40	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	25.41	0.60	2.39	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	27.82	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	15.18	0.00	3.30	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	21.77	0.00	1.62	0.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	27.67	0.97	1.46	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	18.41	1.19	1.78	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	28.62	0.38	1.88	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	23.95	0.73	1.45	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	17.55	0.00	2.51	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	28.17	0.33	0.66	0.82
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	30.03	1.36	0.00	1.36
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	26.84	0.15	0.60	0.75
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	30.00	0.54	3.75	0.54
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	33.25	0.76	1.70	0.38
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	23.79	1.07	0.53	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	19.51	2.93	0.98	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	29.19	0.33	1.00	0.33
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	14.41	0.00	1.20	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	14.16	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	29.50	0.17	1.54	0.51
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	29.36	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	28.64	0.00	1.94	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	35.29	0.38	1.14	0.76
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	18.17	1.21	1.21	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	24.51	0.57	1.14	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	26.72	1.07	1.50	0.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	16.52	0.52	1.81	0.77
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	19.71	0.00	0.94	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	20.26	0.96	1.29	1.29
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	14.98	0.00	1.43	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	18.72	0.00	1.75	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	24.39	0.30	0.90	0.60
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	16.63	0.00	2.38	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	30.51	0.51	1.02	1.02
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	33.36	0.76	1.27	1.27
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	12.07	0.64	3.18	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	21.58	0.00	2.16	0.86
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	26.88	0.42	1.91	0.21
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	17.69	0.58	2.61	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	26.45	0.00	3.78	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	25.09	0.51	0.17	0.51
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	2.32	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	44.36	2.11	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	28.52	0.64	0.86	0.43
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	19.25	0.60	1.20	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	24.79	0.73	3.64	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	29.19	0.69	2.30	0.23
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	25.50	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	28.47	0.25	0.76	0.51
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	29.93	1.03	0.62	0.41
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	17.44	1.22	1.84	0.61
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	26.77	1.43	3.82	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	30.82	1.11	2.00	0.89
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	21.36	0.00	3.05	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	21.60	0.55	1.66	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	29.92	0.79	3.18	0.79
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	22.53	0.36	2.18	0.36
Astrocyte - cerebellum, donor1	11500-119F6	62.88	0.74	1.47	0.25
Astrocyte - cerebellum, donor2	11580-120F5	26.02	0.68	0.51	0.17
Astrocyte - cerebellum, donor3	11661-122F5	15.10	0.21	0.84	0.21
Astrocyte - cerebral cortex, donor1	11235-116D2	89.59	1.39	1.39	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	70.86	1.62	1.94	0.00
Astrocyte - cerebral cortex, donor3	11392-118C6	66.23	1.94	1.34	0.30
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	118.13	2.18	0.80	0.46
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	132.05	2.38	1.75	0.88
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	127.79	2.39	1.37	0.57
Basophils, donor1	12241-129G9	81.86	0.52	1.05	1.05
Basophils, donor2	12242-129H1	132.41	1.44	0.72	0.36
Basophils, donor3	12243-129H2	81.29	1.18	0.44	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	26.52	0.00	0.86	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	7.77	0.00	0.91	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	14.35	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	28.87	0.00	0.63	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	24.54	0.21	0.00	0.21
Bronchial Epithelial Cell, donor6	11461-119B3	20.04	0.23	0.00	0.23
Bronchial Epithelial Cell, donor7	11769-123I5	29.87	0.36	0.72	0.18
Burkitt's lymphoma cell line:DAUDI	10422-106C8	116.97	2.37	1.55	2.16
Burkitt's lymphoma cell line:RAJI	10476-106I8	117.38	2.10	4.19	0.93
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	79.30	1.28	0.96	0.96
CD133+ stem cells - cord blood derived, pool1	12223-129E9	113.76	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	62.55	3.94	0.56	0.56
CD14+ Monocytes, donor2	11305-117B9	53.82	0.74	0.56	0.37
CD14+ Monocytes, donor3	11381-118B4	59.71	1.54	0.44	0.44
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	85.20	0.85	2.83	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	90.22	1.14	3.03	0.38
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	101.58	0.33	1.64	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	62.73	1.01	1.45	0.29
CD14+ monocytes - mock treated, donor2	11873-125C1	57.93	0.60	0.00	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	74.38	2.61	0.24	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	43.86	0.50	0.50	0.17
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	50.51	1.38	0.28	0.28
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	48.10	1.24	0.74	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	38.38	0.78	0.98	0.98
CD14+ monocytes - treated with BCG, donor2	11870-125B7	46.83	0.36	0.53	0.53
CD14+ monocytes - treated with BCG, donor3	11880-125C8	62.02	1.52	1.09	0.22
CD14+ monocytes - treated with Candida, donor1	11868-125B5	39.80	0.94	2.11	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	54.39	3.70	1.58	0.53
CD14+ monocytes - treated with Candida, donor3	11888-125D7	36.61	1.11	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	50.13	0.30	1.34	0.45
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	52.88	0.80	2.20	0.60
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	56.63	0.83	1.04	0.62
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	43.47	0.69	1.37	0.69
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	48.41	1.36	0.23	0.45
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	44.08	0.87	0.87	0.44
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	48.69	0.54	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	68.91	0.70	1.57	0.70
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	64.39	1.26	0.84	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	30.68	0.92	1.47	0.73
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	31.35	1.06	0.00	1.41
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	36.85	0.88	1.32	0.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	43.07	0.52	0.87	0.17
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	50.92	2.23	1.49	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	69.62	1.51	0.65	0.22
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	31.53	0.82	2.46	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	40.10	2.09	0.23	0.23
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	45.93	0.46	0.93	0.46
CD14+CD16+ Monocytes, donor1	11789-124B7	60.38	1.74	0.44	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	67.22	0.46	1.62	0.69
CD14+CD16+ Monocytes, donor3	11912-125G4	48.74	0.65	0.43	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	94.06	1.25	0.93	0.31
CD14+CD16- Monocytes, donor2	11799-124C8	70.91	0.87	1.22	0.17
CD14+CD16- Monocytes, donor3	11910-125G2	103.46	0.67	0.67	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	59.71	0.26	1.28	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	57.53	1.32	0.88	0.44
CD14-CD16+ Monocytes, donor3	11911-125G3	66.74	1.05	0.63	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	119.91	4.06	0.00	2.03
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	151.87	2.03	2.03	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	154.30	1.04	2.07	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	157.25	0.53	0.53	2.13
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	191.91	0.00	1.61	1.07
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	159.34	1.40	0.00	2.81
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	128.63	0.78	2.35	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	142.37	0.00	2.64	3.95
CD19+ B Cells, donor1	11544-120B5	219.45	2.47	4.11	1.64
CD19+ B Cells, donor2	11624-122B4	187.16	1.45	3.63	0.00
CD19+ B Cells, donor3	11705-123B4	168.61	1.51	2.02	1.51
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	168.49	3.64	1.62	1.21
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	107.06	2.80	1.60	0.80
CD34+ Progenitors, donor1	11545-120B6	50.20	0.00	0.00	2.01
CD34+ Progenitors, donor2	11625-122B5	79.78	2.81	0.00	2.25
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	106.34	1.88	3.38	3.01
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	98.99	3.61	1.35	2.48
CD4+ T Cells, donor1	11225-116C1	155.32	0.36	0.36	0.36
CD4+ T Cells, donor2	11306-117C1	105.94	0.61	1.84	1.84
CD4+ T Cells, donor3	11382-118B5	111.32	0.30	0.91	0.30
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	99.80	0.00	0.77	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	101.52	0.45	1.57	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	94.29	0.86	1.44	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	109.99	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	135.55	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	118.66	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	88.01	1.01	1.16	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	67.45	0.34	2.20	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	68.67	0.32	2.42	0.32
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	108.94	0.90	1.34	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	92.59	1.05	0.35	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	127.15	0.44	1.76	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	93.18	0.42	1.69	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	69.60	0.62	3.74	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	59.14	0.33	2.34	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	149.29	0.82	1.36	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	173.65	1.07	1.61	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	120.15	0.00	3.59	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	107.73	1.30	1.85	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	94.66	0.22	1.08	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	99.19	0.21	0.84	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	112.24	0.00	1.01	1.52
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	110.91	0.00	1.30	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	169.53	0.87	0.44	0.87
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	151.43	0.49	0.99	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	132.94	0.92	0.92	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	82.35	0.00	1.40	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	181.11	0.83	1.11	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	228.95	1.72	1.23	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	189.42	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	170.82	0.36	1.79	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	132.96	0.00	2.77	0.00
CD8+ T Cells, donor1	11226-116C2	152.89	0.65	0.33	0.33
CD8+ T Cells, donor2	11307-117C2	119.76	0.00	1.88	1.13
CD8+ T Cells, donor3	11383-118B6	146.44	0.50	0.76	0.50
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	39.46	0.92	2.98	0.46
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	36.43	1.44	1.92	0.24
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	33.10	1.92	2.74	0.27
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	59.74	2.10	3.00	0.60
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	39.12	2.40	2.64	0.96
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	37.29	2.96	4.32	0.45
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	39.33	1.30	4.78	0.65
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	35.01	0.79	2.63	0.53
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	33.54	1.17	1.88	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	54.04	2.72	5.74	1.21
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	42.70	1.16	4.94	0.29
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	49.02	1.07	2.66	0.80
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	36.77	2.63	3.50	1.31
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	35.98	2.73	3.64	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	41.77	5.97	4.48	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	38.54	1.80	5.04	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	39.42	1.73	5.18	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	34.88	1.41	3.30	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	47.22	1.58	6.02	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	42.44	2.15	6.15	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	34.62	3.21	4.17	0.32
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	35.19	1.53	4.21	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	41.78	2.36	3.15	0.39
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	38.58	3.78	8.32	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	45.77	4.01	6.42	3.21
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	49.66	2.10	8.39	0.70
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	57.10	3.01	11.02	1.00
Cardiac Myocyte, donor1	11525-119I4	29.24	1.83	0.00	1.83
Cardiac Myocyte, donor2	11605-120I3	38.04	0.00	1.98	0.49
Cardiac Myocyte, donor3	11686-122I3	52.09	0.53	0.63	0.84
Chondrocyte - de diff, donor1	11261-116G1	53.04	0.00	3.81	0.35
Chondrocyte - de diff, donor2	11338-117F6	47.62	1.42	0.71	0.36
Chondrocyte - de diff, donor3	11410-118E6	30.95	0.57	1.37	0.23
Chondrocyte - re diff, donor2	11339-117F7	132.50	1.79	0.90	0.00
Chondrocyte - re diff, donor3	11411-118E7	48.93	0.00	0.40	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	92.50	1.03	1.84	0.46
Ciliary Epithelial Cells, donor2	11323-117D9	50.45	0.43	1.71	0.21
Ciliary Epithelial Cells, donor3	11399-118D4	55.40	0.62	0.71	0.18
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	89.41	1.74	0.46	0.83
Corneal Epithelial Cells, donor1	11526-119I5	12.08	0.00	0.44	0.00
Corneal Epithelial Cells, donor2	11606-120I4	21.61	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	25.82	0.77	0.51	0.26
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	56.79	0.83	0.99	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	61.19	0.63	0.00	1.26
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	51.76	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	37.58	0.11	0.65	0.11
Dendritic Cells - plasmacytoid, donor1	11228-116C4	60.13	1.02	0.00	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	56.80	0.00	0.65	1.31
Dendritic Cells - plasmacytoid, donor3	11385-118B8	63.40	0.48	0.00	0.48
Endothelial Cells - Aortic, donor0	11207-116A1	50.86	0.83	0.67	0.50
Endothelial Cells - Aortic, donor1	11263-116G3	38.73	1.76	0.59	0.59
Endothelial Cells - Aortic, donor2	11340-117F8	47.23	1.41	1.70	0.57
Endothelial Cells - Aortic, donor3	11412-118E8	29.49	1.57	0.39	0.00
Endothelial Cells - Artery, donor1	11264-116G4	42.18	1.16	0.00	1.45
Endothelial Cells - Artery, donor2	11341-117F9	54.35	0.94	0.71	0.24
Endothelial Cells - Artery, donor3	11413-118E9	56.45	0.88	0.18	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	59.40	1.55	0.44	0.89
Endothelial Cells - Lymphatic, donor2	11317-117D3	74.85	0.61	1.83	0.91
Endothelial Cells - Lymphatic, donor3	11393-118C7	81.47	1.13	1.13	1.13
Endothelial Cells - Microvascular, donor1	11265-116G5	57.35	1.19	2.67	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	35.93	1.04	0.52	0.52
Endothelial Cells - Microvascular, donor3	11414-118F1	25.66	0.71	0.57	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	102.83	2.40	1.60	0.80
Endothelial Cells - Thoracic, donor2	11343-117G2	34.07	1.57	1.05	1.05
Endothelial Cells - Umbilical vein, donor1	11243-116E1	118.66	1.37	0.87	0.37
Endothelial Cells - Umbilical vein, donor2	11324-117E1	64.53	1.52	0.00	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	68.76	1.47	0.24	0.37
Endothelial Cells - Vein, donor1	11267-116G7	32.99	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	34.23	1.40	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	37.37	0.94	0.00	0.16
Eosinophils, donor1	12244-129H3	91.48	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	450.52	3.30	3.30	3.30
Eosinophils, donor3	12246-129H5	281.78	0.00	0.00	3.57
Esophageal Epithelial Cells, donor1	11507-119G4	21.26	0.49	0.49	0.24
Esophageal Epithelial Cells, donor2	11587-120G3	12.48	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	16.27	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	44.34	0.41	0.00	0.82
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	12.70	0.11	0.22	0.22
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	18.63	0.00	0.33	0.54
Fibroblast - Aortic Adventitial, donor1	11245-116E3	59.79	0.61	0.97	0.36
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	144.39	2.59	1.09	3.55
Fibroblast - Aortic Adventitial, donor2	11326-117E3	33.75	0.63	0.53	0.74
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	126.48	1.32	1.84	2.37
Fibroblast - Aortic Adventitial, donor3	11401-118D6	54.48	0.33	0.66	0.66
Fibroblast - Cardiac, donor1	11268-116G8	37.65	1.36	0.45	0.91
Fibroblast - Cardiac, donor2	11345-117G4	51.54	1.52	0.76	0.76
Fibroblast - Cardiac, donor3	11417-118F4	21.92	0.16	0.63	0.47
Fibroblast - Cardiac, donor4	11452-119A3	90.02	1.21	0.91	0.61
Fibroblast - Cardiac, donor5	11456-119A7	49.49	0.63	1.14	0.25
Fibroblast - Cardiac, donor6	11460-119B2	54.57	1.36	0.76	0.30
Fibroblast - Choroid Plexus, donor1	11492-119E7	63.65	0.54	0.80	0.94
Fibroblast - Choroid Plexus, donor2	11572-120E6	43.14	0.00	0.43	1.73
Fibroblast - Choroid Plexus, donor3	11653-122E6	43.94	1.46	2.93	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	42.67	0.92	0.69	0.23
Fibroblast - Conjunctival, donor3	11692-122I9	55.63	0.51	0.68	1.36
Fibroblast - Dermal, donor1	11269-116G9	33.81	0.23	0.47	0.23
Fibroblast - Dermal, donor2	11346-117G5	45.75	1.89	0.47	2.36
Fibroblast - Dermal, donor3	11418-118F5	33.97	0.97	0.97	0.36
Fibroblast - Dermal, donor4	11450-119A1	68.05	2.60	1.13	0.45
Fibroblast - Dermal, donor5	11454-119A5	63.50	1.22	0.87	0.35
Fibroblast - Dermal, donor6	11458-119A9	73.90	1.62	2.44	0.16
Fibroblast - Gingival, donor1	11237-116D4	60.18	1.25	0.62	0.42
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	62.88	0.52	0.26	0.79
Fibroblast - Gingival, donor2	11318-117D4	59.30	1.32	2.50	0.00
Fibroblast - Gingival, donor3	11394-118C8	48.34	0.68	0.10	1.06
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	73.76	1.04	3.12	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	32.42	0.35	0.53	0.53
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	68.59	1.40	1.40	0.94
Fibroblast - Gingival, donor6 (control)	11922-125H5	51.93	0.95	0.54	0.41
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	34.23	1.41	0.35	1.06
Fibroblast - Gingival, donor7 (control)	11924-125H7	60.55	1.02	0.73	0.29
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	73.63	1.50	0.95	0.82
Fibroblast - Gingival, donor8 (control)	11926-125H9	68.67	1.76	0.88	0.33
Fibroblast - Gingival, donor9 (control)	11927-125I1	50.92	0.59	0.88	0.44
Fibroblast - Lung, donor1	11270-116H1	35.34	1.36	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	61.18	0.00	1.49	1.49
Fibroblast - Lung, donor3	11419-118F6	40.94	0.63	1.48	0.21
Fibroblast - Lymphatic, donor1	11506-119G3	45.82	0.83	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	25.18	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	5.88	0.56	0.28	0.28
Fibroblast - Mammary, donor1	11540-120B1	95.00	1.62	0.00	1.62
Fibroblast - Mammary, donor2	11620-122A9	11.98	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	23.83	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	78.56	1.16	0.39	0.39
Fibroblast - Periodontal Ligament, donor2	11319-117D5	79.63	1.21	0.91	0.15
Fibroblast - Periodontal Ligament, donor3	11395-118C9	104.34	0.92	0.00	0.92
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	56.48	1.91	0.38	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	42.93	0.54	1.08	0.54
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	30.50	1.04	0.12	0.23
Fibroblast - Pulmonary Artery, donor1	11250-116E8	47.53	0.22	1.55	0.22
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	55.47	0.81	0.20	0.41
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	35.41	0.00	0.67	0.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	26.49	0.00	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	190.51	3.77	2.58	0.20
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	46.71	0.18	0.36	0.36
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	62.48	0.39	0.79	0.59
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	146.22	2.41	2.41	1.20
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	82.15	1.30	1.51	0.22
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	147.29	2.02	1.01	0.25
Fibroblast - skin normal, donor1	11553-120C5	47.09	0.82	0.66	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	214.54	3.01	1.80	1.00
Fibroblast - skin normal, donor2	11561-120D4	80.07	1.71	1.31	0.50
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	229.40	4.84	1.81	1.81
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	58.99	0.75	1.24	0.83
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	75.90	1.03	0.85	0.34
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	132.69	1.31	1.31	0.66
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	75.52	1.81	0.96	0.00
Fibroblast - skin walker warburg, donor1	11554-120C6	62.41	0.17	0.67	0.51
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	29.95	0.63	1.10	0.47
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	265.92	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	71.47	0.87	1.74	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	45.25	1.04	0.69	0.69
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	62.46	1.30	2.08	0.26
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	66.18	0.77	1.53	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	65.07	1.53	3.06	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	85.50	1.91	5.10	1.28
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	126.37	1.43	11.70	1.71
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	88.52	2.48	4.69	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	76.03	2.28	2.51	0.23
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	88.96	1.59	7.53	0.59
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	81.15	1.32	5.29	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	82.52	1.63	1.63	0.98
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	90.21	1.77	9.73	0.44
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	74.48	2.54	0.71	0.14
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	55.17	1.23	1.11	0.25
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	63.66	2.15	2.42	1.88
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	52.41	1.98	0.99	0.25
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	62.71	2.35	0.42	0.83
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	51.84	0.41	1.83	1.02
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	44.04	1.14	0.23	0.46
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	48.58	2.12	0.75	0.87
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	45.25	2.19	1.09	0.87
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	53.78	0.89	1.77	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	58.18	1.11	0.95	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	49.60	0.89	1.12	0.22
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	50.61	1.41	2.02	0.40
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	54.62	3.22	1.02	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	78.39	1.51	1.06	0.89
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	83.24	1.14	1.25	0.52
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	82.66	1.37	0.51	0.51
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	58.54	2.10	0.66	0.33
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	71.22	1.41	1.25	0.67
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	63.91	0.41	0.41	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	50.34	0.62	1.44	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	57.99	1.61	0.58	0.12
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	46.03	1.00	0.83	0.33
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	39.68	0.66	1.32	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	56.82	1.60	1.35	0.74
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	50.09	0.65	1.13	0.16
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	45.54	0.64	2.89	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	43.21	1.04	0.28	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	43.02	0.47	0.95	0.79
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	53.22	1.52	0.30	0.30
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	47.25	1.36	0.52	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	46.55	0.44	0.88	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	50.22	0.56	1.96	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	41.85	1.39	0.56	0.19
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	41.98	1.07	1.34	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	46.67	0.77	1.38	0.31
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	40.80	1.04	0.78	0.52
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	41.47	1.08	1.36	0.54
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	49.22	0.92	1.47	0.37
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	44.30	0.66	1.10	0.66
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	55.54	1.98	0.99	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	41.82	0.92	1.58	0.26
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	39.75	0.00	0.81	0.61
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	100.65	0.76	0.25	0.51
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	127.80	3.38	1.39	1.19
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	78.42	1.85	0.92	0.92
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	123.98	3.89	1.02	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	78.23	0.94	3.76	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	77.70	1.13	2.54	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	123.14	3.23	4.61	1.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	69.29	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	97.48	2.71	4.25	1.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	68.99	1.60	1.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	76.51	0.00	1.74	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	74.53	0.98	1.30	1.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	89.36	1.24	2.06	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	93.30	0.00	10.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	77.18	1.12	3.08	1.12
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	89.88	1.63	1.96	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	79.69	2.52	5.03	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	83.65	0.32	2.23	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	79.14	1.02	1.70	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	66.82	2.09	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	66.43	1.72	2.29	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	56.83	1.18	1.18	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	57.60	0.00	3.39	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	74.56	2.49	3.73	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	81.70	2.76	2.99	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	21.07	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	63.43	1.54	1.54	0.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	57.70	1.63	1.96	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	30.10	0.00	1.34	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	75.51	1.16	2.31	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	113.66	1.03	3.42	1.71
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	34.79	0.00	4.97	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	63.70	0.00	1.89	0.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	62.16	0.60	3.62	1.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	66.13	1.53	2.03	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	73.39	1.60	2.39	0.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	74.99	0.99	1.48	1.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	69.65	1.18	1.18	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	53.09	2.33	1.17	1.17
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	48.28	2.19	2.63	0.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	54.25	0.85	3.39	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	58.50	0.60	2.39	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	56.77	1.94	0.97	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	31.96	1.14	0.00	1.14
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	29.94	0.00	1.66	1.25
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	13.49	2.25	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	28.54	0.00	0.95	2.22
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	16.29	0.00	0.84	2.09
Hep-2 cells mock treated, biol_rep1	11898-125E8	39.92	0.93	3.25	0.58
Hep-2 cells mock treated, biol_rep2	11899-125E9	44.90	1.52	2.03	0.34
Hep-2 cells mock treated, biol_rep3	11900-125F1	40.50	1.14	2.05	0.91
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	37.27	1.20	2.73	0.33
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	36.96	1.07	1.72	0.21
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	40.04	1.08	1.08	0.86
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	36.74	1.62	2.62	0.12
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	36.20	1.89	1.72	0.17
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	38.77	1.28	0.96	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	36.94	1.68	0.56	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	14.28	0.43	0.43	0.43
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	39.66	2.64	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	41.27	0.35	0.35	0.35
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	19.62	0.73	0.73	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	52.28	0.17	1.40	0.35
Hepatocyte, donor1	11523-119I2	69.00	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	54.94	0.00	0.00	1.08
Hepatocyte, donor3	11684-122I1	83.44	1.84	0.00	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	63.31	0.65	2.61	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	57.15	1.57	0.35	0.52
Iris Pigment Epithelial Cells, donor1	11530-119I9	54.47	0.69	0.82	0.27
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	85.97	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	33.38	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	27.08	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	62.30	1.38	0.00	4.15
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	40.04	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	59.34	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	58.95	2.56	0.00	2.56
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	18.28	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	55.23	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	33.35	0.00	0.00	1.67
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	29.04	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	54.26	1.32	0.00	6.62
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	35.48	2.22	0.00	1.11
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	20.95	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	35.90	1.26	0.00	0.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	26.29	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	14.63	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	31.66	3.23	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	48.30	0.00	0.00	1.61
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	23.90	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	42.37	0.00	0.00	0.81
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	51.64	1.26	0.00	2.10
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	14.37	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	50.63	1.61	0.00	0.80
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	44.32	2.77	0.00	0.92
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	33.51	1.89	0.94	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	43.54	2.72	0.00	1.81
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	88.45	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	38.74	1.08	0.00	1.08
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	54.63	0.00	0.00	1.27
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	49.29	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	44.64	2.55	0.64	3.83
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	49.21	3.65	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	47.13	1.43	0.00	2.86
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	59.73	3.32	0.00	3.32
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	62.55	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	36.42	0.31	0.93	0.31
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	87.80	7.02	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	66.01	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	60.50	4.17	0.00	1.39
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	42.05	0.00	0.00	2.21
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	32.42	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	29.65	0.87	0.00	0.87
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	27.00	2.25	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	34.85	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	29.87	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	36.02	1.39	0.00	2.77
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	48.44	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	26.69	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	30.25	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	43.46	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	24.32	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	46.19	0.73	1.14	0.49
Keratinocyte - epidermal, donor2	11349-117G8	29.28	1.17	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	42.31	0.76	0.57	0.19
Keratinocyte - oral, donor1	11251-116E9	85.93	0.68	1.14	1.36
Keratocytes, donor1	11527-119I6	48.14	1.03	0.69	0.69
Keratocytes, donor2	11607-120I5	21.09	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	36.95	0.40	0.40	0.20
Krukenberg tumor cell line:HSKTC	10687-109F3	41.76	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	31.28	0.00	2.16	0.00
Lens Epithelial Cells, donor2	11609-120I7	59.05	0.81	0.35	0.23
Lens Epithelial Cells, donor3	11690-122I7	68.82	1.51	0.30	0.50
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	49.57	0.36	1.07	0.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	27.35	0.56	1.12	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	57.46	0.63	2.36	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	24.20	0.54	1.08	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	30.57	0.63	1.58	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	29.00	0.54	1.29	0.22
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	28.32	0.41	1.64	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	20.73	0.76	1.26	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	36.31	0.56	2.25	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	27.29	1.19	2.77	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	26.56	0.00	1.36	0.39
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	18.89	0.93	1.30	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	29.96	0.70	1.05	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	24.81	0.24	0.95	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	29.94	0.96	1.79	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	26.18	1.54	2.16	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	15.28	0.62	0.94	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	34.22	0.18	2.20	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	25.67	0.66	2.96	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	19.04	0.00	0.59	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	24.15	0.50	1.99	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	27.64	0.48	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	27.20	0.54	2.69	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	38.30	1.06	2.57	0.15
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	23.33	0.00	1.56	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	34.55	0.21	2.30	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	33.68	0.75	1.50	0.15
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	31.64	2.06	0.69	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	27.28	0.94	1.88	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	23.33	0.21	0.95	0.11
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	29.07	0.97	2.42	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	20.51	0.00	0.66	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	26.02	0.25	1.36	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	39.61	1.85	1.48	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	21.74	0.74	1.24	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	21.59	0.55	1.24	0.14
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	28.63	0.96	0.96	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	38.95	0.30	1.22	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	34.43	0.70	2.52	0.28
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	30.22	1.07	1.42	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	16.00	0.48	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	22.87	0.47	0.78	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	23.28	0.72	1.43	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	30.71	0.98	0.98	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	20.01	0.24	3.06	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	60.27	0.74	1.24	0.62
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	18.70	0.51	1.02	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	30.73	0.00	1.49	0.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	24.93	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	22.25	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	19.30	1.48	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	22.00	0.85	0.00	0.42
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	16.18	0.00	0.70	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	12.14	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	17.52	0.52	1.03	1.03
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	19.03	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	21.26	1.13	0.23	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	32.28	0.29	0.87	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	39.17	0.00	0.45	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	30.48	0.41	0.14	0.14
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	29.27	0.00	0.51	0.51
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	37.05	1.06	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	21.99	0.00	0.00	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	26.49	0.51	1.02	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	41.09	1.07	0.27	0.53
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	38.36	0.94	0.76	0.19
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	18.41	0.00	0.61	0.61
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	39.14	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	38.73	1.04	1.46	0.21
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	33.07	0.84	1.68	0.56
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	25.76	1.03	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	33.38	1.16	0.87	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	33.18	0.60	0.60	0.30
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	38.73	0.00	2.21	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	27.93	0.71	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	24.71	1.48	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	24.18	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	23.79	0.38	0.00	0.38
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	26.04	0.00	0.57	1.70
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	19.69	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	23.05	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	28.01	0.72	0.72	0.72
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	24.65	0.00	0.75	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	24.90	1.11	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	20.25	0.00	0.86	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	23.98	0.86	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	31.65	0.67	0.33	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	16.89	1.21	1.21	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	19.91	0.00	0.71	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	31.62	0.00	0.34	0.34
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	22.01	0.54	0.54	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	21.55	0.67	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	26.30	0.74	0.37	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	19.77	1.16	0.00	1.16
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	16.92	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	20.81	0.80	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	17.44	0.73	0.00	0.73
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	31.43	0.00	0.00	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	25.65	0.00	0.49	0.49
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	16.00	0.94	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	29.67	0.50	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	26.59	0.45	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	27.54	1.72	1.72	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	27.61	0.00	0.89	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	24.24	0.39	0.00	0.39
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	18.47	0.66	0.00	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	21.28	1.56	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	32.82	0.88	0.88	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	30.75	1.12	0.56	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	29.15	0.88	0.00	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	37.41	1.16	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	22.79	1.52	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	34.12	0.48	0.48	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	26.24	1.99	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	27.34	0.61	0.61	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	26.28	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	29.26	0.00	1.14	0.38
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	19.62	0.52	0.52	0.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	18.74	0.60	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	24.40	0.00	0.63	0.32
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	21.32	0.00	1.07	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	18.39	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	21.08	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	18.39	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	21.56	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	21.22	0.83	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	17.23	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	18.79	0.84	0.42	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	18.59	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	9.37	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	19.25	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	20.61	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	25.70	0.92	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	20.45	0.00	0.89	0.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	22.22	0.00	0.00	1.14
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	13.04	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	18.60	0.55	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	17.37	0.89	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	23.40	0.26	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	23.21	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	20.79	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	56.98	0.46	1.14	0.00
Macrophage - monocyte derived, donor2	11313-117C8	46.06	0.18	1.10	0.18
Macrophage - monocyte derived, donor3	11389-118C3	39.06	0.26	0.52	0.13
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	32.39	1.06	1.06	1.06
Mallassez-derived cells, donor2	11929-125I3	47.54	1.11	0.48	0.95
Mallassez-derived cells, donor3	11930-125I4	57.68	0.42	0.97	0.83
Mammary Epithelial Cell, donor1	11273-116H4	76.83	1.20	2.29	1.10
Mammary Epithelial Cell, donor2	11350-117G9	61.67	0.87	2.61	0.58
Mammary Epithelial Cell, donor3	11422-118F9	34.17	0.25	0.50	0.25
Mast cell - stimulated, donor1	11487-119E2	206.77	0.68	0.68	2.03
Mast cell, donor1	11563-120D6	119.50	1.41	0.76	0.54
Mast cell, donor2	11565-120D8	157.80	2.38	0.59	0.59
Mast cell, donor3	11566-120D9	176.27	2.93	2.93	1.58
Mast cell, donor4	11567-120E1	161.69	3.55	1.95	0.53
Mast cell, expanded and stimulated, donor5	11940-126A5	115.55	1.11	0.78	0.33
Mast cell, expanded and stimulated, donor8	11942-126A7	119.65	1.17	0.58	0.58
Mast cell, expanded, donor5	11939-126A4	89.37	0.57	1.03	0.46
Mast cell, expanded, donor8	11941-126A6	93.89	1.34	1.34	0.84
Melanocyte - dark, donor1	11502-119F8	67.76	0.60	0.80	0.40
Melanocyte - dark, donor2	11582-120F7	34.95	1.38	3.46	0.00
Melanocyte - dark, donor3	11663-122F7	87.58	1.01	1.81	0.22
Melanocyte - light, donor1	11274-116H5	26.09	0.94	0.24	0.00
Melanocyte - light, donor2	11351-117H1	21.16	0.00	0.68	0.68
Melanocyte - light, donor3	11423-118G1	18.21	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	43.21	1.04	1.04	0.10
Melanocyte, donor2 (MC+2)	12739-135I3	38.46	0.27	2.15	0.54
Melanocyte, donor3 (MC+3)	12837-137B2	55.98	0.80	0.80	0.54
Meningeal Cells, donor1	11493-119E8	98.26	2.85	0.50	0.12
Meningeal Cells, donor2	11573-120E7	61.62	1.32	0.44	0.00
Meningeal Cells, donor3	11654-122E7	65.77	0.49	2.04	0.24
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	60.17	1.14	3.14	0.57
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	42.67	1.01	0.91	1.01
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	10.51	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	14.39	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	27.99	0.00	1.44	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	43.84	0.64	0.85	0.21
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	29.66	0.50	0.50	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	49.44	0.44	1.32	0.66
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	32.88	0.00	1.46	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	24.35	0.41	1.23	0.82
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	39.20	0.14	0.42	0.97
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	18.59	0.37	0.74	0.37
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	43.02	0.66	0.53	2.89
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	21.96	0.00	0.00	1.78
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	9.34	0.00	0.00	2.34
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	28.82	1.28	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	63.09	1.42	3.19	0.35
Mesenchymal stem cells - hepatic, donor0	11218-116B3	36.28	1.25	0.31	0.31
Mesenchymal stem cells - umbilical, donor0	11214-116A8	42.82	0.00	0.73	0.00
Mesothelial Cells, donor1	11247-116E5	38.19	0.53	1.33	1.59
Mesothelial Cells, donor2	12156-128G5	31.03	0.50	0.50	0.00
Mesothelial Cells, donor3	11402-118D7	27.68	0.65	0.36	0.29
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	25.66	0.00	1.35	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	44.82	0.49	0.74	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	37.40	0.29	0.59	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	17.29	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	35.95	0.93	0.93	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	25.31	0.00	0.83	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	2.32	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	39.54	0.50	1.50	0.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	33.98	0.47	1.40	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	30.08	0.41	0.61	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	32.07	0.79	1.58	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	17.10	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	29.20	0.88	0.88	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	23.56	0.38	1.14	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	9.21	1.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	29.29	0.85	1.27	0.21
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	10.13	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	28.61	0.00	0.60	0.30
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	16.77	1.68	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	25.34	0.50	1.25	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	23.53	0.24	0.71	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	15.48	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	26.94	0.46	0.69	0.23
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	27.98	0.21	0.00	0.42
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	25.48	0.41	0.20	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	27.46	0.43	1.29	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	25.34	0.00	0.22	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	24.97	0.22	0.88	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	15.21	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	16.57	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	22.29	1.36	0.54	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	25.59	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	13.08	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	19.70	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	32.82	0.40	0.40	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	10.97	0.00	1.37	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	24.53	0.00	2.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	53.89	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	10.19	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	33.28	0.88	0.88	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	23.18	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	17.29	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	41.40	0.25	0.25	0.25
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	13.22	2.09	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	15.47	2.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	39.32	0.34	1.37	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	17.50	0.44	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	19.89	1.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	35.35	0.28	1.68	0.28
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	30.76	1.66	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	16.32	0.58	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	36.20	1.81	0.60	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	30.47	0.42	1.25	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	21.66	7.22	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	28.63	0.00	0.92	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	38.70	0.57	0.57	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	32.75	0.41	0.14	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	39.39	0.26	1.04	0.26
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	32.17	0.43	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	15.24	1.27	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	32.03	0.27	0.27	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	37.72	0.00	0.30	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	26.98	0.28	0.00	0.14
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	33.13	0.32	1.27	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	47.76	0.66	0.44	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	23.13	1.14	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	51.71	0.28	0.57	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	39.82	0.49	0.49	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	24.76	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	44.40	0.59	0.00	0.29
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	40.94	0.58	1.15	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	56.46	0.41	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	31.56	0.60	0.89	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	22.60	0.00	11.30	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	19.60	0.00	1.78	1.78
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	42.06	0.33	1.64	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	23.14	1.05	3.16	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	45.47	0.79	4.35	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	34.46	1.86	0.93	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	41.68	0.75	2.63	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	27.17	0.00	1.07	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	40.04	0.68	1.13	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	28.00	0.00	0.74	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	36.28	0.73	1.83	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	31.11	1.56	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	27.79	1.60	1.60	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	15.46	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	31.31	0.00	8.08	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	26.14	0.00	2.53	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	32.69	0.00	0.00	2.72
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	11.44	0.00	1.27	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	11.34	0.00	1.62	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	34.74	0.00	3.02	1.51
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	74.23	0.00	0.00	5.71
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	52.20	3.26	0.00	3.26
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	28.51	4.75	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	50.20	12.55	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	49.98	1.08	0.65	0.43
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	40.76	0.00	0.52	0.52
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	25.36	2.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	27.13	0.83	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	97.92	0.19	0.95	0.38
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	65.43	3.19	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	21.76	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	66.16	1.84	7.35	3.68
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	27.20	1.26	0.00	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	43.47	1.86	0.23	0.46
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	20.54	0.54	0.00	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	41.63	0.00	1.05	0.42
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	200.42	0.00	11.13	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	35.74	0.50	0.50	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	33.29	0.27	1.35	0.81
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	28.11	0.23	0.45	0.23
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	20.74	0.33	0.00	0.49
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	27.52	0.91	0.73	0.55
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	28.11	0.00	0.00	1.59
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	23.41	1.20	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	80.08	0.33	1.31	0.66
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	21.47	0.16	0.16	0.16
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	39.86	0.71	0.00	0.35
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	27.43	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	27.12	0.00	0.00	0.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	26.35	0.00	0.32	1.29
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	75.88	0.69	1.72	1.03
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	116.31	0.00	7.59	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	30.52	0.22	0.45	0.67
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	20.32	0.00	0.85	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	40.59	0.71	0.24	0.47
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	29.62	0.86	0.43	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	225.69	0.00	27.08	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	26.32	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	21.19	0.45	0.45	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	17.86	0.00	0.40	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	35.29	0.00	0.00	0.93
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	37.46	1.14	0.38	1.14
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	19.23	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	20.05	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	32.11	0.45	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	17.64	0.00	0.00	0.88
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	26.59	0.00	0.66	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	25.30	0.50	0.00	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	19.52	0.38	0.00	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	54.74	0.91	0.30	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	35.81	1.11	0.66	0.44
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	17.62	0.00	1.36	0.68
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	71.53	0.00	20.44	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	25.61	0.61	0.00	1.22
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	23.61	0.00	0.00	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	23.61	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	28.48	0.00	0.00	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	69.15	2.27	1.13	1.13
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	80.93	0.00	10.12	0.00
Myoblast, donor1	11241-116D8	47.08	1.12	0.99	1.24
Myoblast, donor2	11322-117D8	46.60	0.58	1.15	1.15
Myoblast, donor3	11398-118D3	68.78	0.67	0.67	0.67
NK T cell leukemia cell line:KHYG-1	10777-110G3	67.13	0.29	1.46	0.88
Natural Killer Cells, donor1	11230-116C6	148.22	0.62	1.23	1.54
Natural Killer Cells, donor2	11311-117C6	110.07	0.30	1.81	2.71
Natural Killer Cells, donor3	11387-118C1	119.64	1.47	0.74	2.02
Neural stem cells, donor1	11275-116H6	150.98	2.54	0.00	0.36
Neural stem cells, donor2	11352-117H2	194.49	1.93	0.00	0.00
Neurons, donor1	11494-119E9	85.34	1.14	2.28	1.14
Neurons, donor2	11574-120E8	79.26	1.10	2.42	0.00
Neurons, donor3	11655-122E8	63.31	0.82	2.47	0.00
Neutrophils, donor1	11233-116C9	276.55	1.86	2.78	0.93
Neutrophils, donor2	11314-117C9	191.33	0.00	0.00	2.90
Neutrophils, donor3	11390-118C4	463.63	3.67	0.61	1.22
Nucleus Pulposus Cell, donor1	11252-116F1	82.64	1.42	2.14	2.14
Nucleus Pulposus Cell, donor2	11409-118E5	31.91	0.00	0.33	0.65
Nucleus Pulposus Cell, donor3	11462-119B4	30.08	0.60	0.80	0.20
Olfactory epithelial cells, donor1	11933-125I7	37.30	0.83	1.38	0.00
Olfactory epithelial cells, donor2	11934-125I8	46.75	0.43	3.04	0.43
Olfactory epithelial cells, donor3	11935-125I9	27.81	0.34	0.91	0.11
Olfactory epithelial cells, donor4	11936-126A1	44.02	0.58	0.68	1.17
Oligodendrocyte - precursors, donor1	11496-119F2	63.79	0.00	1.20	0.00
Osteoblast - differentiated, donor1	11276-116H7	30.63	0.21	0.00	1.28
Osteoblast - differentiated, donor2	11353-117H3	11.43	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	18.00	0.62	0.00	1.24
Osteoblast, donor1	11277-116H8	60.39	0.78	0.59	0.20
Osteoblast, donor2	11354-117H4	80.77	0.70	2.11	0.70
Osteoblast, donor3	11426-118G4	49.59	0.53	0.36	0.00
Pancreatic stromal cells, donor1	11249-116E7	61.41	0.76	1.10	0.76
Pericytes, donor1	11491-119E6	15.91	0.56	0.11	0.11
Pericytes, donor2	11571-120E5	14.94	1.13	0.45	0.00
Pericytes, donor3	11652-122E5	25.23	0.61	0.81	0.20
Perineurial Cells, donor1	11499-119F5	66.57	0.45	1.02	0.68
Perineurial Cells, donor2	11579-120F4	75.17	1.01	0.74	0.83
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	156.18	0.96	1.27	0.32
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	68.32	0.98	0.49	0.49
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	90.72	1.04	0.65	0.26
Placental Epithelial Cells, donor1	11278-116H9	35.40	1.20	1.91	0.24
Placental Epithelial Cells, donor2	11355-117H5	32.16	1.11	1.11	1.11
Placental Epithelial Cells, donor3	11427-118G5	30.23	0.98	0.39	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	16.14	0.00	0.63	0.00
Preadipocyte - breast, donor1	11467-119B9	37.89	0.75	0.38	0.56
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	161.98	2.48	1.57	1.04
Preadipocyte - breast, donor2	11328-117E5	30.85	0.45	0.90	0.45
Preadipocyte - omental, donor1	11468-119C1	39.53	0.85	0.75	1.17
Preadipocyte - omental, donor2	11329-117E6	48.88	0.44	0.00	0.87
Preadipocyte - omental, donor3	11403-118D8	47.13	0.29	1.00	0.29
Preadipocyte - perirenal, donor1	11469-119C2	29.53	0.98	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	31.94	0.61	0.61	0.92
Preadipocyte - subcutaneous, donor2	11356-117H6	59.14	1.24	2.48	1.59
Preadipocyte - subcutaneous, donor3	11428-118G6	40.02	0.51	1.19	0.34
Preadipocyte - visceral, donor1	11280-116I2	90.35	0.75	1.77	2.14
Preadipocyte - visceral, donor2	11357-117H7	48.78	0.92	1.38	0.46
Preadipocyte - visceral, donor3	11429-118G7	48.07	0.94	1.99	0.21
Prostate Epithelial Cells (polarized), donor1	11253-116F2	61.70	1.36	0.45	0.91
Prostate Epithelial Cells, donor2	11331-117E8	26.41	0.81	1.49	0.68
Prostate Epithelial Cells, donor3	11404-118D9	31.84	0.61	0.73	0.06
Prostate Stromal Cells, donor1	11254-116F3	59.23	1.48	0.23	0.68
Prostate Stromal Cells, donor2	11332-117E9	46.26	1.43	3.77	0.18
Prostate Stromal Cells, donor3	11405-118E1	25.44	1.04	0.31	0.63
Renal Cortical Epithelial Cells, donor1	11516-119H4	32.48	0.00	0.36	0.36
Renal Cortical Epithelial Cells, donor2	11596-120H3	43.46	0.90	1.39	0.35
Renal Epithelial Cells, donor1	11517-119H5	16.23	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	23.47	0.00	0.00	0.71
Renal Epithelial Cells, donor3	11678-122H4	52.19	0.95	1.48	0.42
Renal Glomerular Endothelial Cells, donor1	11514-119H2	21.79	0.68	2.04	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	36.52	0.81	1.08	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	60.83	1.11	1.11	0.44
Renal Glomerular Endothelial Cells, donor4	11783-124B1	9.32	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	34.11	0.88	0.66	0.00
Renal Mesangial Cells, donor2	11598-120H5	30.72	2.51	0.63	0.00
Renal Mesangial Cells, donor3	11679-122H5	11.37	0.28	0.00	0.28
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	61.74	1.61	1.34	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	19.40	0.42	2.11	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	29.51	0.77	0.77	0.19
Retinal Pigment Epithelial Cells, donor0	11215-116A9	42.00	1.04	1.30	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	54.29	0.85	1.42	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	15.44	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	38.39	1.25	1.25	0.75
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	73.23	1.20	1.47	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	69.69	0.00	2.68	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	159.06	1.10	3.30	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	151.39	1.16	0.58	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	136.79	1.82	1.69	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	74.38	1.59	1.69	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	115.67	2.68	0.78	0.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	147.61	2.48	2.73	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	77.97	0.70	1.52	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	102.85	1.62	2.31	0.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	104.19	2.19	0.55	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	84.56	0.76	0.30	0.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	101.78	1.61	0.90	0.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	87.65	2.15	1.43	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	79.41	0.86	2.15	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	82.53	1.55	1.99	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	104.00	1.53	0.57	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	83.47	1.02	1.12	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	150.14	0.94	2.25	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	97.01	1.86	0.80	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	89.26	1.75	0.68	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	92.04	0.76	1.72	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	95.37	1.60	0.43	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	80.45	0.84	1.96	0.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	88.53	1.88	1.03	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	90.44	2.01	1.46	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	83.76	1.10	1.59	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	90.26	1.48	1.61	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	89.87	1.42	2.36	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	91.87	1.19	3.17	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	87.93	1.40	3.04	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	99.12	1.87	1.87	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	86.27	2.43	0.88	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	88.15	1.46	1.04	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	95.42	0.94	1.48	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	93.66	1.19	0.68	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	91.96	1.16	0.96	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	87.00	1.89	1.03	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	85.32	1.51	0.41	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	78.80	1.97	1.97	0.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	101.07	1.19	0.68	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	100.61	1.63	1.78	0.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	94.36	1.87	0.80	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	97.48	1.11	0.83	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	80.00	0.95	2.62	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	104.20	1.01	0.40	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	85.42	1.13	1.98	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	88.74	1.75	2.10	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	88.85	1.81	1.81	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	97.66	1.35	1.10	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	206.54	2.77	1.02	0.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	103.43	1.83	3.04	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	105.79	0.90	1.81	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	83.92	1.36	2.71	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	112.33	1.80	2.40	1.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	121.14	1.53	0.94	0.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	96.69	1.71	1.28	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	110.58	0.00	3.00	0.00
Schwann Cells, donor1	11498-119F4	22.76	0.75	0.75	0.19
Schwann Cells, donor2	11578-120F3	34.02	0.00	3.40	0.00
Schwann Cells, donor3	11659-122F3	44.04	1.31	1.53	0.44
Sebocyte, donor1	11220-116B5	70.11	1.10	1.10	0.00
Sebocyte, donor2	11301-117B5	35.85	0.46	0.46	0.46
Sebocyte, donor3	11378-118B1	24.73	0.21	0.21	0.21
Sertoli Cells, donor1	11255-116F4	84.49	0.00	3.31	0.00
Sertoli Cells, donor2	11333-117F1	36.72	0.00	5.65	0.00
Skeletal Muscle Cells, donor1	11281-116I3	58.42	0.97	0.62	0.53
Skeletal Muscle Cells, donor2	11358-117H8	13.73	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	40.13	1.67	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	66.14	0.94	1.73	0.47
Skeletal Muscle Cells, donor5	11455-119A6	53.81	0.74	2.82	0.89
Skeletal Muscle Cells, donor6	11459-119B1	63.56	1.54	2.31	0.46
Skeletal Muscle Satellite Cells, donor1	11240-116D7	95.26	1.89	2.02	3.02
Skeletal Muscle Satellite Cells, donor2	11321-117D7	49.66	2.14	1.71	1.14
Skeletal Muscle Satellite Cells, donor3	11397-118D2	69.45	1.49	1.09	0.40
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	65.80	0.51	1.60	1.10
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	29.67	1.45	0.72	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	20.23	0.41	0.55	0.00
Skin - palm, donor1	10286-104F7	75.21	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	21.05	1.30	0.00	0.14
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	162.76	4.09	0.00	0.82
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	29.08	0.65	0.65	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	48.79	0.70	1.67	0.00
Small Airway Epithelial Cells, donor2	11334-117F2	42.20	0.84	0.42	0.00
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	206.37	2.75	0.85	2.11
Small Airway Epithelial Cells, donor3	11406-118E2	34.78	0.75	0.30	0.15
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	12.96	0.93	0.31	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	69.37	1.56	0.22	2.45
Smooth Muscle Cells - Aortic, donor0	11210-116A4	41.74	2.35	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	38.89	0.44	0.22	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	45.28	0.79	1.18	0.39
Smooth Muscle Cells - Aortic, donor3	11432-118H1	28.58	1.55	1.55	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	43.03	0.00	2.00	7.01
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	42.85	0.80	0.13	0.93
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	37.68	1.33	1.77	0.22
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	44.55	0.77	0.38	0.77
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	57.30	0.65	0.98	0.98
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	56.11	1.18	1.18	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	31.89	0.43	0.43	0.28
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	12.53	0.33	0.00	0.16
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	33.79	0.30	0.61	0.61
Smooth Muscle Cells - Carotid, donor1	11285-116I7	43.95	1.52	0.00	0.76
Smooth Muscle Cells - Carotid, donor2	11362-117I3	24.48	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	27.66	1.43	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	47.04	0.44	0.29	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	36.16	1.08	1.08	0.65
Smooth Muscle Cells - Colonic, donor3	11396-118D1	39.67	1.57	0.73	0.42
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	49.65	0.46	1.24	1.55
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	25.87	1.08	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	29.59	0.60	0.30	0.90
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	14.68	0.68	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	53.01	0.86	1.33	4.63
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	51.33	0.50	0.70	1.81
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	31.17	0.46	0.91	0.23
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	27.17	0.00	0.60	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	109.68	1.06	0.79	0.53
Smooth Muscle Cells - Prostate, donor1	11257-116F6	69.11	1.60	1.46	0.40
Smooth Muscle Cells - Prostate, donor2	11335-117F3	41.95	1.13	1.25	0.75
Smooth Muscle Cells - Prostate, donor3	11465-119B7	39.57	0.76	1.01	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	53.68	0.30	1.06	1.21
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	31.51	0.75	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	24.55	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	55.34	0.93	0.93	0.93
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	19.19	0.00	3.03	1.01
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	21.62	0.63	1.88	0.63
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	13.27	0.29	0.29	1.47
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	111.21	1.67	0.50	0.75
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	24.29	1.40	0.47	1.87
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	36.27	1.01	0.58	1.15
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	34.42	0.76	0.25	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	31.03	1.13	0.38	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	89.72	1.12	1.40	0.56
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	51.61	0.84	1.09	0.25
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	10.00	0.00	0.00	0.95
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	30.34	0.73	0.49	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	50.16	0.88	1.33	0.22
Smooth Muscle Cells - Uterine, donor3	11466-119B8	58.22	0.29	0.59	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	29.93	0.58	0.97	0.39
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	21.42	0.00	0.53	0.26
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	43.52	0.00	2.23	1.12
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	29.82	1.44	0.72	1.44
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	18.45	0.57	0.57	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	40.96	0.79	2.76	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	38.60	0.76	1.52	0.76
Smooth muscle cells - airway, control, donor2	11967-126D5	33.94	0.80	1.60	0.80
Smooth muscle cells - airway, control, donor3	11968-126D6	21.74	0.00	1.25	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	29.79	1.38	0.46	0.46
Synoviocyte, donor1	11291-117A4	41.74	0.34	0.50	0.34
Synoviocyte, donor2	11368-117I9	34.20	0.50	1.84	0.84
Synoviocyte, donor3	11440-118H9	25.69	0.45	1.79	0.89
Trabecular Meshwork Cells, donor1	11532-120A2	40.02	0.71	1.43	1.07
Trabecular Meshwork Cells, donor2	11612-122A1	17.84	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	19.22	0.69	0.23	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	49.96	0.36	1.36	0.50
Tracheal Epithelial Cells, donor2	11369-118A1	23.19	0.39	0.00	0.39
Tracheal Epithelial Cells, donor3	11441-118I1	19.47	1.72	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	76.77	0.62	0.62	0.25
Urethra, donor2	10319-105A4	86.32	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	16.47	0.27	0.27	0.27
Urothelial Cells, donor2	11600-120H7	23.23	0.80	0.00	0.00
Urothelial Cells, donor3	11681-122H7	12.15	0.23	0.00	0.00
Urothelial cells, donor0	11216-116B1	56.84	0.89	3.34	0.89
Whole blood (ribopure), donor090309, donation1	12179-129A1	198.42	1.78	0.89	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	191.57	1.43	2.86	1.43
Whole blood (ribopure), donor090309, donation3	12181-129A3	87.62	2.05	0.68	0.68
Whole blood (ribopure), donor090325, donation1	12176-128I7	152.54	2.41	1.38	0.69
Whole blood (ribopure), donor090325, donation2	12177-128I8	151.07	0.58	0.58	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	188.46	1.04	4.16	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	178.05	2.75	0.92	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	92.20	1.83	2.74	0.00
Wilms' tumor cell line:G-401	10809-111A8	71.92	2.71	1.85	0.86
Wilms' tumor cell line:HFWT	10597-108E3	16.72	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	57.26	1.12	0.84	0.56
achilles tendon, donor2	10292-104G4	28.93	2.07	2.07	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	127.48	1.78	2.80	0.76
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	153.00	2.09	3.71	6.04
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	148.74	3.09	0.83	3.21
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	148.57	2.45	0.82	1.36
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	91.35	2.53	2.53	0.84
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	80.79	1.69	1.06	0.42
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	65.88	2.45	0.82	0.54
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	79.31	1.76	0.44	1.32
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	82.49	2.45	1.63	2.04
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	92.80	1.55	0.78	0.78
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	58.70	2.21	1.47	0.74
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	105.31	3.90	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	97.37	1.16	2.32	0.23
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	104.34	4.14	1.04	0.78
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	71.02	4.38	3.51	0.88
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	44.15	1.39	1.39	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	55.11	1.23	0.82	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	40.21	0.92	0.92	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	74.67	4.27	2.56	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	96.75	2.73	3.34	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	84.25	3.37	1.20	0.24
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	67.49	2.00	1.78	1.34
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	63.71	1.00	0.67	1.67
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	70.61	1.86	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	81.74	0.75	1.88	4.14
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	97.26	4.80	0.00	3.49
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	86.23	3.75	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	51.57	1.18	0.00	0.00
adipose tissue, adult, pool1	10010-101C1	91.05	0.93	0.47	0.47
adipose, donor1	10184-103D4	194.69	2.35	11.14	0.59
adipose, donor2	10185-103D5	52.72	1.22	2.84	0.00
adipose, donor3	10186-103D6	74.06	1.36	3.27	0.27
adipose, donor4	10187-103D7	65.87	6.07	3.47	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	50.34	1.42	0.16	0.00
adrenal gland, adult, pool1	10081-102A9	65.48	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	71.91	1.47	1.07	0.53
alveolar cell carcinoma cell line:SW 1573	10708-109H6	62.53	2.14	2.14	0.00
amniotic membrane cells, donor1	12235-129G3	62.60	0.93	0.46	0.00
amniotic membrane cells, donor2	12236-129G4	74.38	1.01	0.68	0.34
amniotic membrane cells, donor3	12237-129G5	64.22	0.00	0.00	0.00
amygdala - adult, donor10196	10167-103B5	65.22	0.00	0.00	0.00
amygdala, adult, donor10252	10151-102I7	73.60	2.03	1.22	0.20
amygdala, newborn, donor10223	10360-105E9	46.16	1.61	1.29	0.65
anaplastic carcinoma cell line:8305C	10428-106D5	66.08	1.15	0.89	0.64
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	57.58	1.32	1.54	0.66
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	98.21	0.67	1.00	0.67
aorta, adult, pool1	10052-101G7	66.88	0.78	0.98	0.20
appendix, adult	10189-103D9	85.77	1.55	0.00	0.39
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	69.47	3.44	4.13	1.03
artery, adult	10190-103E1	89.67	2.72	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	108.94	1.30	2.17	0.14
b cell line:RPMI1788	10427-106D4	83.57	2.53	1.34	0.45
basal cell carcinoma cell line:TE 354.T	10702-109G9	47.72	0.28	0.28	0.28
bile duct carcinoma cell line:HuCCT1	10432-106D9	63.61	1.49	1.09	0.50
bile duct carcinoma cell line:TFK-1	10496-107C1	64.11	0.33	1.17	0.50
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	43.62	0.00	1.12	0.00
bladder, adult, pool1	10011-101C2	66.81	1.52	0.65	0.33
blood, adult, pool1	10053-101G8	62.01	0.00	2.21	2.21
bone marrow stromal cell line:StromaNKtert	10686-109F2	65.94	1.71	0.00	0.00
bone marrow, adult	10192-103E3	49.26	1.35	0.67	1.35
brain, adult, donor1	10084-102B3	62.53	1.03	3.08	0.00
brain, adult, pool1	10012-101C3	84.52	1.11	0.56	0.22
brain, fetal, pool1	10085-102B4	64.11	2.67	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	43.94	1.65	0.33	0.33
breast carcinoma cell line:MDA-MB-453	10419-106C5	123.08	0.50	0.75	1.12
breast, adult, donor1	10080-102A8	35.99	0.63	1.26	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	48.78	1.14	1.02	0.00
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	59.68	0.93	1.24	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	55.71	1.84	1.61	0.46
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	40.91	0.24	0.73	0.73
carcinoid cell line:NCI-H1770	10703-109H1	91.21	2.82	3.76	0.47
carcinoid cell line:NCI-H727	10735-110B6	32.38	0.33	0.00	0.44
carcinoid cell line:SK-PN-DW	10719-109I8	61.16	0.63	1.58	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	74.26	3.19	1.33	0.53
caudate nucleus - adult, donor10196	10177-103C6	75.99	2.30	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	68.10	0.84	0.33	0.00
caudate nucleus, adult, donor10258	10379-105H1	57.31	0.76	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	56.40	1.83	0.73	0.73
cerebellum - adult, donor10196	10173-103C2	142.75	0.00	2.91	0.00
cerebellum, adult, donor10252	10166-103B4	160.77	1.07	0.64	0.43
cerebellum, adult, pool1	10083-102B2	60.37	0.34	1.38	0.00
cerebellum, newborn, donor10223	10357-105E6	104.62	0.83	0.83	0.00
cerebral meninges, adult	10188-103D8	40.34	1.01	1.01	0.00
cerebrospinal fluid, donor2	10294-104G6	47.51	1.46	2.19	1.46
cervical cancer cell line:D98-AH2	10552-107I3	99.64	1.44	3.02	1.44
cervical cancer cell line:ME-180	10553-107I4	56.68	0.50	1.49	0.00
cervix, adult, pool1	10013-101C4	91.34	1.36	1.57	0.52
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	63.54	0.84	1.53	0.42
chondrosarcoma cell line:SW 1353	10700-109G7	22.21	2.61	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	92.59	1.86	1.24	0.50
choriocarcinoma cell line:SCH	10785-110H2	60.25	0.74	1.85	0.37
choriocarcinoma cell line:T3M-3	10618-108G6	66.88	1.42	1.66	0.24
chorionic membrane cells, donor1	12238-129G6	62.11	0.85	0.28	0.00
chorionic membrane cells, donor2	12239-129G7	76.36	0.70	0.89	0.20
chorionic membrane cells, donor3	12240-129G8	68.14	0.55	0.55	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	54.53	1.01	2.02	4.04
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	80.49	1.73	1.54	0.38
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	98.20	1.48	1.06	1.06
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	57.52	2.05	1.28	0.51
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	71.11	1.45	0.73	0.73
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	65.36	1.02	0.61	1.63
chronic myelogenous leukemia cell line:K562	10454-106G4	95.99	1.77	1.77	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	189.47	3.13	2.61	2.09
clear cell carcinoma cell line:JHOC-5	10638-108I8	46.86	0.91	1.83	0.23
clear cell carcinoma cell line:TEN	10636-108I6	66.63	0.87	1.39	0.35
colon carcinoma cell line:CACO-2	10513-107D9	58.57	0.92	1.65	0.55
colon carcinoma cell line:COLO-320	10420-106C6	109.08	4.94	1.52	0.38
colon, adult, donor1	10082-102B1	66.64	0.00	2.38	0.00
colon, adult, pool1	10014-101C5	82.72	0.82	1.29	0.12
colon, fetal, donor1	10070-101I7	48.20	2.47	1.85	0.00
common myeloid progenitor CMP, donor1	12130-128D6	87.09	18.33	0.00	4.58
common myeloid progenitor CMP, donor2	12134-128E1	125.18	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	99.43	5.10	1.27	2.97
cord blood derived cell line:COBL-a 24h infection	10453-106G3	83.92	2.57	1.21	1.36
cord blood derived cell line:COBL-a untreated	10449-106F8	101.11	2.12	1.69	1.41
corpus callosum, adult, pool1	10042-101F6	116.09	1.99	0.22	0.44
cruciate ligament, donor2	10295-104G7	67.27	0.81	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	54.57	2.41	0.80	0.00
diencephalon, adult	10193-103E4	45.12	1.44	0.24	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	89.55	1.84	2.98	1.61
ductal cell carcinoma cell line:KLM-1	10438-106E6	74.88	1.28	1.80	1.28
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	96.53	0.96	2.17	3.37
ductus deferens, adult	10196-103E7	78.24	1.00	1.50	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	59.05	0.00	1.44	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	72.83	0.74	2.21	0.00
dura mater, adult, donor1	10041-101F5	143.87	1.65	0.74	0.33
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	57.74	3.78	2.22	2.66
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	67.35	1.86	1.86	1.29
embryonic pancreas cell line:1B2C6	10604-108F1	30.21	0.62	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	29.36	0.61	0.61	1.51
embryonic pancreas cell line:1C3IKEI	10606-108F3	38.90	2.78	0.62	0.00
embryonic pancreas cell line:2C6	10603-108E9	64.36	2.63	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	62.01	1.34	1.01	0.67
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	78.47	0.91	1.81	0.00
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	49.05	0.80	1.13	0.48
epidermoid carcinoma cell line:A431	10426-106D3	97.49	0.89	1.22	0.67
epidermoid carcinoma cell line:Ca Ski	10431-106D8	86.12	0.88	0.99	0.11
epididymis, adult	10197-103E8	69.07	2.09	0.84	0.63
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	70.79	2.48	1.24	1.06
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	32.25	1.97	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	95.27	2.62	1.97	1.05
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	95.17	2.36	1.77	0.59
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	88.28	2.80	2.02	0.56
esophagus, adult, pool1	10015-101C6	67.32	0.74	0.64	0.32
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	105.32	2.63	0.38	2.25
eye - muscle inferior rectus, donor1	10272-104E2	79.68	2.41	2.41	0.00
eye - muscle lateral, donor2	10298-104H1	48.40	4.21	0.00	6.31
eye - muscle medial, donor2	10299-104H2	44.65	2.98	1.49	0.00
eye - muscle superior, donor2	10297-104G9	48.15	3.44	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	24.78	1.46	0.00	0.00
eye, fetal, donor1	10054-101G9	63.05	0.51	2.03	0.51
fibrosarcoma cell line:HT-1080	10758-110E2	58.47	0.90	1.54	0.51
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	46.06	1.19	0.71	0.95
frontal lobe, adult, pool1	10040-101F4	121.88	1.88	0.47	0.28
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	118.90	3.90	1.50	0.90
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	51.02	1.19	0.37	0.18
gall bladder, adult	10198-103E9	62.05	1.93	0.97	0.48
gamma delta positive T cells, donor1	11937-126A2	131.53	1.07	2.68	0.00
gamma delta positive T cells, donor2	11938-126A3	153.51	0.00	1.87	0.37
gastric adenocarcinoma cell line:MKN1	10614-108G2	50.48	0.42	1.27	0.21
gastric adenocarcinoma cell line:MKN45	10612-108F9	72.53	0.97	0.77	0.39
gastric cancer cell line:AZ521	10549-107H9	106.24	2.79	1.97	1.48
gastric cancer cell line:GSS	10560-108A2	42.10	0.00	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	78.59	1.60	1.60	0.23
giant cell carcinoma cell line:LU65	10487-107B1	40.27	1.72	1.15	0.23
giant cell carcinoma cell line:Lu99B	10433-106E1	51.78	0.28	1.12	0.14
glassy cell carcinoma cell line:HOKUG	10688-109F4	60.36	2.74	0.50	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	54.47	1.69	0.63	0.32
glioblastoma cell line:A172, tech_rep2	10444-106F3	60.67	0.84	0.42	0.42
glioblastoma cell line:T98G	10485-107A8	85.43	0.99	2.21	0.66
glioma cell line:GI-1	10413-106B8	69.12	1.46	0.88	0.88
globus pallidus - adult, donor10196	10175-103C4	49.57	0.00	1.46	0.00
globus pallidus, adult, donor10252	10161-103A8	103.74	1.71	1.22	0.49
globus pallidus, adult, donor10258	10367-105F7	46.55	1.37	1.37	0.00
globus pallidus, newborn, donor10223	10364-105F4	38.90	0.53	1.07	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	80.76	2.45	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	65.57	10.93	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	20.91	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	45.44	0.96	0.96	0.00
hIPS +CCl2, biol_rep1	14383-156B9	66.57	2.30	1.84	1.38
hIPS +CCl2, biol_rep2	14384-156C1	72.25	2.29	3.20	0.91
hIPS +CCl2, biol_rep3	14385-156C2	74.07	1.93	3.86	1.93
hIPS, biol_rep1	14380-156B6	57.49	0.00	2.87	1.44
hIPS, biol_rep2	14381-156B7	43.90	1.37	2.74	0.69
hIPS, biol_rep3	14382-156B8	51.86	2.21	2.21	0.00
hairy cell leukemia cell line:Mo	10712-109I1	74.42	0.57	0.57	0.29
heart - mitral valve, adult	10205-103F7	61.59	0.90	0.30	0.30
heart - pulmonic valve, adult	10206-103F8	72.95	2.88	0.78	0.78
heart - tricuspid valve, adult	10207-103F9	54.12	1.67	0.83	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	48.16	0.41	0.61	1.43
heart, adult, diseased, donor1	10051-101G6	47.69	1.28	0.43	2.55
heart, adult, pool1	10016-101C7	58.64	1.15	0.46	0.92
heart, fetal, pool1	10046-101G1	140.57	1.64	0.31	0.82
hepatic mesenchymal tumor cell line:LI90	10778-110G4	43.50	0.00	0.31	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	63.03	4.76	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	102.87	2.54	1.22	0.99
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	116.88	2.31	0.97	0.73
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	123.28	2.32	1.62	1.01
hepatoma cell line:Li-7	10484-107A7	57.16	0.67	1.33	0.44
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	86.83	2.31	2.21	0.40
hippocampus - adult, donor10196	10169-103B7	63.40	0.95	0.95	0.00
hippocampus, adult, donor10252	10153-102I9	81.03	1.02	1.02	0.61
hippocampus, adult, donor10258	10374-105G5	55.27	0.00	1.00	0.00
hippocampus, newborn, donor10223	10363-105F3	33.49	0.70	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	123.90	0.61	10.38	3.05
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	70.49	1.57	3.14	1.18
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	74.90	1.02	5.33	0.25
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	54.13	2.82	2.26	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	69.20	1.03	1.81	0.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	64.91	1.14	4.56	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	75.91	1.75	3.50	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	73.03	1.94	1.08	0.22
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	60.89	1.25	3.34	1.25
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	84.06	2.13	2.13	0.24
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	80.20	1.93	5.14	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	94.94	1.35	2.02	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	75.43	0.78	2.82	0.94
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	82.54	1.97	2.46	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	111.71	0.87	9.60	2.62
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	73.88	0.76	1.91	0.38
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	65.85	1.31	2.18	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	85.96	3.50	4.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	51.81	3.58	1.32	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	53.66	1.36	1.82	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	48.86	0.31	4.39	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	57.81	1.47	1.80	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	65.32	1.16	3.48	0.29
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	60.38	1.49	5.68	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	83.14	1.29	4.25	1.29
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	73.60	1.43	5.71	1.14
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	93.10	1.22	9.80	1.22
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	80.27	2.82	2.11	0.70
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	60.81	1.58	3.17	0.32
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	60.83	1.21	3.93	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	61.02	2.59	2.59	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	63.10	0.66	5.31	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	52.59	0.77	2.05	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	60.84	1.02	1.53	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	70.42	1.51	5.30	1.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	60.15	1.34	2.35	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	80.18	1.69	5.55	0.24
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	81.11	1.34	8.47	1.78
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	78.54	1.46	3.90	0.98
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	78.85	0.61	2.14	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	494.49	0.00	13.01	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	86.71	2.98	3.64	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	81.00	1.64	0.55	0.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	58.26	1.45	1.09	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	58.01	2.49	1.78	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	48.93	1.19	1.19	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	107.39	2.71	1.35	0.41
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	48.22	0.81	3.23	0.27
immature langerhans cells, donor1	11904-125F5	97.58	2.42	0.48	0.00
immature langerhans cells, donor2	11905-125F6	60.20	1.58	1.58	0.79
insula, adult, pool1	10039-101F3	128.99	1.70	0.57	0.28
keratoacanthoma cell line:HKA-1	10791-110H8	52.02	0.00	0.65	0.00
kidney, adult, pool1	10017-101C8	76.10	0.30	0.60	0.50
kidney, fetal, pool1	10045-101F9	96.91	2.12	0.21	0.14
large cell lung carcinoma cell line:IA-LM	10509-107D5	112.62	4.40	0.71	0.99
large cell lung carcinoma cell line:NCI-H460	10839-111E2	25.16	1.11	0.83	0.14
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	39.45	1.83	0.55	0.00
left atrium, adult, donor1	10079-102A7	35.96	0.00	0.54	0.00
left ventricle, adult, donor1	10078-102A6	39.95	0.00	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	59.37	1.92	0.00	0.55
leiomyoma cell line:10964C	10569-108B2	20.84	1.44	1.08	0.36
leiomyoma cell line:15242A	10570-108B3	27.17	0.54	2.17	0.54
leiomyoma cell line:15425	10571-108B4	24.77	0.73	0.97	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	12.70	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	53.32	1.05	2.09	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	108.38	1.53	1.77	1.06
liposarcoma cell line:KMLS-1	10782-110G8	40.30	0.47	0.31	0.16
liposarcoma cell line:SW 872	10726-110A6	51.05	1.46	1.46	0.61
liver, adult, pool1	10018-101C9	84.11	1.13	0.32	0.16
liver, fetal, pool1	10086-102B5	34.81	0.00	0.94	0.00
locus coeruleus - adult, donor10196	10182-103D2	49.73	0.73	0.44	0.00
locus coeruleus, adult, donor10252	10165-103B3	75.11	1.29	1.29	0.37
locus coeruleus, adult, donor10258	10375-105G6	50.50	0.56	1.41	0.00
locus coeruleus, newborn, donor10223	10362-105F2	67.30	0.84	0.84	0.42
lung adenocarcinoma cell line:A549	10499-107C4	39.44	1.11	0.83	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	71.01	1.38	0.69	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	42.97	2.11	0.13	0.13
lung, adult, pool1	10019-101D1	72.65	1.18	0.71	0.35
lung, fetal, donor1	10068-101I5	190.65	4.28	0.86	0.29
lung, right lower lobe, adult, donor1	10075-102A3	54.99	1.37	1.37	0.00
lymph node, adult, donor1	10077-102A5	56.80	0.47	1.42	0.47
lymphangiectasia cell line:DS-1	10727-110A7	55.45	0.44	1.32	0.88
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	110.48	2.72	1.81	1.51
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	131.67	3.40	0.85	0.85
mature adipocyte, donor1	12231-129F8	61.71	3.11	0.89	0.89
mature adipocyte, donor2	12232-129F9	58.94	2.28	0.00	1.25
mature adipocyte, donor3	12233-129G1	60.45	3.32	0.47	1.90
mature adipocyte, donor4	12234-129G2	98.97	3.42	0.26	0.26
maxillary sinus tumor cell line:HSQ-89	10414-106B9	136.28	4.05	1.19	0.48
medial frontal gyrus - adult, donor10196	10170-103B8	85.73	1.13	1.13	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	76.14	1.29	0.55	0.55
medial frontal gyrus, adult, donor10258	10368-105F8	51.78	0.00	1.91	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	111.74	3.84	0.85	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	78.64	1.35	0.34	0.17
medial temporal gyrus, adult, donor10252	10156-103A3	86.16	1.49	0.42	0.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	73.20	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	444.96	0.00	43.06	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	50.61	1.44	1.08	0.00
medulla oblongata - adult, donor10196	10174-103C3	53.87	2.60	1.95	0.00
medulla oblongata, adult, donor10252	10155-103A2	77.87	0.31	0.46	0.77
medulla oblongata, adult, pool1	10038-101F2	93.22	2.12	0.41	0.24
medulla oblongata, newborn, donor10223	10361-105F1	40.27	0.69	1.39	2.08
medulloblastoma cell line:D283 Med	10838-111E1	97.64	3.32	1.33	0.44
medulloblastoma cell line:ONS-76	10759-110E3	52.09	0.98	0.12	0.86
melanoma cell line:COLO 679	10514-107E1	68.42	0.57	1.29	1.29
melanoma cell line:G-361	10465-106H6	74.38	1.09	0.54	0.54
meningioma cell line:HKBMM	10691-109F7	23.34	0.18	0.72	0.36
merkel cell carcinoma cell line:MKL-1	10843-111E6	105.74	2.64	0.88	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	122.87	2.85	1.04	0.26
mesenchymal precursor cell - adipose, donor1	11747-123G1	63.37	0.00	0.92	0.77
mesenchymal precursor cell - adipose, donor2	11748-123G2	36.54	0.00	0.73	0.91
mesenchymal precursor cell - adipose, donor3	11749-123G3	41.41	0.83	2.90	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	43.27	1.26	0.28	0.42
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	53.15	0.39	0.19	0.58
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	38.87	2.08	1.39	1.39
mesenchymal precursor cell - cardiac, donor1	11752-123G6	27.63	0.34	0.86	0.51
mesenchymal precursor cell - cardiac, donor2	11753-123G7	38.30	0.46	0.81	0.00
mesenchymal precursor cell - cardiac, donor3	11754-123G8	54.65	1.33	0.40	0.13
mesenchymal precursor cell - cardiac, donor4	11755-123G9	55.10	1.22	1.08	0.54
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	53.06	0.71	0.43	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	46.11	0.66	0.66	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	57.84	1.11	0.55	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	38.40	0.70	1.40	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	42.67	1.02	1.22	0.20
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	38.82	0.00	0.72	0.72
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	35.17	0.31	0.41	0.10
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	29.18	0.91	0.91	0.91
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	65.45	0.42	1.68	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	55.29	0.60	0.45	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	45.34	1.14	0.79	0.18
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	30.93	1.47	0.74	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	39.78	2.00	0.86	0.57
mesenchymal stem cell line:Hu5/E18	10568-108B1	62.73	1.26	2.95	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	43.84	0.91	0.46	0.91
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	40.67	1.53	2.30	0.77
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	46.07	0.52	1.57	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	39.44	1.23	1.54	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	43.54	0.00	0.94	0.94
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	46.71	0.34	1.69	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	38.90	1.18	3.93	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	45.41	0.00	2.78	0.93
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	59.13	2.02	1.44	0.87
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	48.41	0.89	0.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	49.03	0.96	2.40	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	48.40	0.00	0.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	36.92	1.34	0.67	1.01
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	40.53	0.82	3.68	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	42.96	0.86	1.72	1.72
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	57.42	0.00	2.73	2.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	36.15	0.00	5.16	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	41.25	0.97	0.97	0.32
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	45.10	2.91	7.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	46.91	0.53	2.67	0.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	42.52	0.00	1.64	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	35.76	0.78	1.94	1.17
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	25.18	0.00	4.20	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	51.66	0.00	1.99	1.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	42.90	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	55.74	0.59	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	60.92	1.22	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	108.21	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	38.00	1.90	1.90	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	31.73	0.00	2.07	1.72
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	45.13	2.15	0.00	4.30
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	19.96	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	41.33	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	23.63	0.00	0.81	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	25.42	0.00	0.79	1.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	21.81	0.00	1.18	2.95
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	21.20	0.31	0.94	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	22.72	0.00	1.34	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	17.74	0.00	1.18	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	30.82	0.00	2.57	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	25.47	0.00	1.38	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	34.14	0.99	0.99	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	30.28	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	27.35	0.64	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	27.81	1.61	0.40	0.40
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	37.07	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	24.07	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	33.38	0.61	2.43	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	36.15	0.00	9.04	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	26.36	0.00	2.47	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	34.72	0.99	0.79	0.40
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	28.56	0.32	1.30	0.65
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	27.50	1.02	1.02	1.02
mesodermal tumor cell line:HIRS-BM	10696-109G3	46.42	2.32	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	73.71	0.71	1.65	0.47
mesothelioma cell line:ACC-MESO-4	10494-107B8	74.14	0.93	0.70	0.23
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	42.74	4.27	0.00	8.55
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	74.39	0.31	0.82	0.62
mesothelioma cell line:Mero-25	10850-111F4	32.23	0.45	0.45	0.45
mesothelioma cell line:Mero-41	10851-111F5	59.65	1.22	0.49	0.49
mesothelioma cell line:Mero-48a	10852-111F6	43.18	1.55	1.99	0.22
mesothelioma cell line:Mero-82	10853-111F7	56.24	0.79	2.37	0.53
mesothelioma cell line:Mero-83	10854-111F8	57.02	1.36	1.02	1.53
mesothelioma cell line:Mero-84	10855-111F9	29.32	1.01	1.01	0.00
mesothelioma cell line:Mero-95	10856-111G1	48.24	1.45	0.83	0.21
mesothelioma cell line:NCI-H2052	10847-111F1	43.23	0.83	0.99	1.16
mesothelioma cell line:NCI-H226	10846-111E9	39.09	1.09	1.27	1.09
mesothelioma cell line:NCI-H2452	10848-111F2	41.00	1.02	0.51	0.85
mesothelioma cell line:NCI-H28	10845-111E8	49.37	2.04	2.29	0.76
mesothelioma cell line:No36	10857-111G2	41.10	0.65	1.30	0.65
mesothelioma cell line:ONE58	10858-111G3	41.46	0.81	1.90	1.35
migratory langerhans cells, donor1	11901-125F2	136.65	1.34	0.96	2.30
migratory langerhans cells, donor2	11902-125F3	84.75	1.59	0.37	0.00
migratory langerhans cells, donor3	11903-125F4	117.56	1.97	0.18	0.54
mixed mullerian tumor cell line:HTMMT	10689-109F5	25.47	0.33	0.65	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	36.88	0.42	2.12	0.21
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	33.17	0.23	0.46	0.23
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	52.33	0.76	0.95	0.19
myelodysplastic syndrome cell line:SKM-1	10772-110F7	127.88	1.48	2.03	0.74
myeloma cell line:PCM6	10474-106I6	50.80	0.59	0.59	0.40
myxofibrosarcoma cell line:MFH-ino	10600-108E6	24.35	1.01	0.51	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	50.80	1.37	0.59	1.37
nasal epithelial cells, donor1, tech_rep1	12226-129F3	33.76	0.56	0.56	0.33
nasal epithelial cells, donor1, tech_rep2	12226-129F3	35.15	0.44	0.74	0.22
nasal epithelial cells, donor2	12227-129F4	65.69	0.55	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	69.02	2.99	0.46	0.00
neuroblastoma cell line:NB-1	10539-107G8	69.03	0.75	0.37	0.37
neuroblastoma cell line:NBsusSR	10607-108F4	99.96	1.27	1.48	0.21
neuroblastoma cell line:NH-12	10555-107I6	54.04	1.68	0.37	0.19
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	68.32	0.47	2.37	0.47
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	83.31	0.32	3.96	0.48
neuroectodermal tumor cell line:TASK1	10774-110F9	68.83	1.41	2.01	0.40
neuroepithelioma cell line:SK-N-MC	10728-110A8	48.32	0.00	0.64	0.64
neurofibroma cell line:Hs 53.T	10729-110A9	38.06	0.53	1.06	0.00
neutrophil PMN, donor1	12133-128D9	29.75	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	26.56	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	94.71	9.47	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	159.31	3.72	1.86	4.23
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	51.23	0.80	0.80	0.80
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	45.85	1.60	0.96	0.96
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	36.52	0.00	0.79	0.26
nucleus accumbens, adult, pool1	10037-101F1	104.99	1.12	0.37	0.28
occipital cortex - adult, donor10196	10172-103C1	113.32	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	104.39	1.88	1.07	0.54
occipital cortex, newborn, donor10223	10355-105E4	49.13	1.46	0.36	0.00
occipital lobe, adult, donor1	10076-102A4	69.01	1.31	0.79	0.00
occipital lobe, fetal, donor1	10073-102A1	79.38	1.29	2.15	0.00
occipital pole, adult, pool1	10036-101E9	73.40	1.58	0.24	0.08
olfactory region, adult	10195-103E6	61.33	0.96	0.57	0.19
optic nerve, donor1	10277-104E7	68.04	4.00	2.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	61.51	0.80	1.25	1.14
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	61.27	0.69	0.69	0.69
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	61.46	0.85	1.35	0.34
oral squamous cell carcinoma cell line:SAS	10544-107H4	64.11	0.81	1.04	0.00
osteoclastoma cell line:Hs 706.T	10704-109H2	39.69	0.88	0.59	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	71.94	0.93	0.93	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	87.37	3.18	1.27	0.42
ovary, adult, pool1	10020-101D2	78.09	3.41	0.52	0.26
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	37.40	0.37	0.92	0.73
pancreas, adult, donor1	10049-101G4	63.02	1.88	0.94	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	53.11	0.84	1.68	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	43.61	0.68	0.85	0.17
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	61.27	0.99	0.33	0.83
paracentral gyrus, adult, pool1	10035-101E8	102.32	1.46	0.46	0.64
parietal cortex, adult, donor10258	10373-105G4	50.65	1.47	0.73	0.00
parietal lobe - adult, donor10196	10171-103B9	63.01	0.00	2.82	0.94
parietal lobe, adult, donor10252	10157-103A4	82.66	0.57	0.86	0.57
parietal lobe, adult, pool1	10034-101E7	100.37	0.88	0.18	0.44
parietal lobe, fetal, donor1	10072-101I9	108.62	1.94	3.88	0.00
parietal lobe, newborn, donor10223	10356-105E5	65.05	1.50	1.50	0.37
parotid gland, adult	10199-103F1	67.83	1.23	0.62	0.00
penis, adult	10200-103F2	80.03	1.61	1.61	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	55.97	2.97	0.56	0.74
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	30.74	0.73	1.60	0.29
pineal gland - adult, donor10196	10179-103C8	67.08	0.65	0.00	0.65
pineal gland, adult, donor10252	10160-103A7	146.87	0.59	1.18	1.18
pineal gland, adult, donor10258	10377-105G8	69.61	0.00	0.00	1.25
pituitary gland - adult, donor10196	10180-103C9	127.49	1.01	1.01	0.00
pituitary gland, adult, donor10252	10162-103A9	191.27	3.13	1.56	1.04
pituitary gland, adult, donor10258	10378-105G9	73.21	2.55	0.85	0.00
placenta, adult, pool1	10021-101D3	95.57	2.04	0.54	0.22
plasma cell leukemia cell line:ARH-77	10840-111E3	54.56	2.25	0.93	0.40
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	68.95	1.25	0.93	0.93
pons, adult, pool1	10033-101E6	91.06	1.81	0.43	0.34
postcentral gyrus, adult, pool1	10032-101E5	84.56	0.87	0.61	0.26
promyelocytes/myelocytes PMC, donor1	12132-128D8	25.10	6.27	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	22.03	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	23.47	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	75.02	1.17	2.04	1.02
prostate cancer cell line:PC-3	10439-106E7	93.47	0.00	1.09	0.18
prostate, adult, pool1	10022-101D4	69.74	1.54	0.27	1.18
putamen, adult, donor10196	10176-103C5	88.52	0.71	0.24	0.24
putamen, adult, donor10252	10152-102I8	45.10	1.96	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	36.06	1.09	2.19	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	55.81	0.97	0.24	0.00
putamen, newborn, donor10223	10365-105F5	113.20	1.50	3.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	73.61	1.75	0.87	0.87
rectum, fetal, donor1	10067-101I4	76.50	0.00	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	49.18	0.42	0.00	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	56.75	0.00	0.83	4.56
retina, adult, pool1	10030-101E3	98.11	1.39	0.40	0.70
retinoblastoma cell line:Y79	10475-106I7	115.09	5.20	3.38	0.52
rhabdomyosarcoma cell line:KYM-1	10787-110H4	64.06	0.86	0.74	0.12
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	125.13	4.50	1.69	1.69
sacrococcigeal teratoma cell line:HTST	10695-109G2	43.96	0.76	1.52	1.52
salivary acinar cells, donor1	11771-123I7	50.50	0.97	0.16	0.81
salivary acinar cells, donor2	11772-123I8	54.52	0.55	0.14	2.07
salivary acinar cells, donor3	11773-123I9	46.34	1.32	0.00	0.66
salivary gland, adult, pool1	10093-102C3	63.49	1.14	0.57	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	57.16	1.43	0.93	0.34
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	66.18	0.71	1.06	0.71
seminal vesicle, adult	10201-103F3	72.48	2.12	1.06	1.06
serous adenocarcinoma cell line:JHOS-2	10639-108I9	61.95	0.97	1.70	0.97
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	41.52	2.01	0.25	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	60.21	0.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	61.92	0.94	1.88	1.21
signet ring carcinoma cell line:Kato III	10436-106E4	81.90	1.22	0.99	0.55
signet ring carcinoma cell line:NUGC-4	10483-107A6	60.38	1.55	1.68	0.77
skeletal muscle - soleus muscle, donor1	10282-104F3	114.20	3.55	0.71	2.13
skeletal muscle, adult, pool1	10023-101D5	107.46	2.40	1.32	2.76
skeletal muscle, fetal, donor1	10066-101I3	49.25	3.02	1.01	0.00
skin, adult, donor1	10074-102A2	27.14	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	92.16	0.00	0.63	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	71.71	2.00	0.67	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	86.68	1.89	1.26	0.63
small cell lung carcinoma cell line:DMS 144	10841-111E4	90.40	4.24	2.51	0.19
small cell lung carcinoma cell line:LK-2	10541-107H1	111.92	1.48	1.65	0.16
small cell lung carcinoma cell line:NCI-H82	10842-111E5	69.00	3.38	0.80	0.16
small cell lung carcinoma cell line:WA-hT	10562-108A4	103.29	1.53	0.65	0.44
small intestine, adult, pool1	10024-101D6	108.10	0.96	1.67	0.12
small intestine, fetal, donor1	10064-101I1	55.28	0.74	0.98	0.00
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	45.65	1.03	4.62	0.00
smooth muscle, adult, pool1	10048-101G3	69.78	1.29	0.78	0.00
somatostatinoma cell line:QGP-1	10781-110G7	64.33	0.80	0.00	0.00
spinal cord - adult, donor10196	10181-103D1	56.43	0.46	0.69	0.46
spinal cord, adult, donor10252	10159-103A6	87.13	0.39	0.39	0.79
spinal cord, adult, donor10258	10369-105F9	60.19	0.00	0.69	0.00
spinal cord, fetal, donor1	10056-101H2	70.13	1.83	1.22	0.00
spinal cord, newborn, donor10223	10359-105E8	95.98	0.92	1.84	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	44.66	0.75	0.30	0.00
spleen, adult, pool1	10025-101D7	92.40	0.66	0.55	0.11
spleen, fetal, pool1	10044-101F8	100.75	1.51	0.56	0.00
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	66.35	2.48	1.04	1.45
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	55.06	0.19	0.19	0.19
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	69.89	0.70	1.40	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	28.93	0.39	0.39	1.17
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	121.34	3.15	3.38	1.46
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	30.08	0.00	0.00	0.42
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	47.38	0.42	0.42	0.85
stomach, fetal, donor1	10062-101H8	55.53	1.07	2.14	0.00
submaxillary gland, adult	10202-103F4	51.84	0.00	1.14	0.00
substantia nigra - adult, donor10196	10178-103C7	162.82	0.00	54.27	0.00
substantia nigra, adult, donor10252	10158-103A5	77.89	0.62	0.62	1.25
substantia nigra, adult, donor10258	10371-105G2	50.17	2.59	1.03	0.00
substantia nigra, newborn, donor10223	10358-105E7	38.86	0.71	2.12	0.71
synovial sarcoma cell line:HS-SY-II	10441-106E9	111.88	1.38	1.60	0.00
temporal lobe, adult, pool1	10031-101E4	74.09	0.93	0.42	0.25
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	95.44	1.42	0.71	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	79.12	3.08	0.88	0.00
tenocyte, donor1	11763-123H8	39.80	0.70	1.75	0.00
tenocyte, donor2	11765-123I1	33.19	0.38	1.91	0.00
tenocyte, donor3	11768-123I4	29.65	0.74	1.48	1.48
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	108.26	2.21	3.40	0.34
teratocarcinoma cell line:NCR-G1	10798-110I6	67.83	1.23	1.85	0.92
teratocarcinoma cell line:PA-1	10807-111A6	90.20	1.24	1.55	1.70
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	135.33	4.57	2.41	1.02
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	155.05	4.54	2.27	3.78
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	163.92	4.04	1.42	2.40
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	112.69	2.61	2.93	0.98
testis, adult, pool1	10026-101D8	105.12	2.25	1.07	1.50
testis, adult, pool2	10096-102C6	110.06	5.86	1.35	0.90
thalamus - adult, donor10196	10168-103B6	81.69	0.00	2.21	0.00
thalamus, adult, donor10252	10154-103A1	86.42	1.25	0.94	0.78
thalamus, adult, donor10258, tech_rep1	10370-105G1	69.28	0.00	0.00	1.54
thalamus, adult, donor10258, tech_rep2	10370-105G1	37.38	0.49	1.48	0.16
thalamus, newborn, donor10223	10366-105F6	51.78	0.58	1.15	0.00
throat, adult	10209-103G2	86.14	1.25	1.00	1.25
throat, fetal, donor1	10061-101H7	85.32	1.22	0.30	0.91
thymic carcinoma cell line:Ty-82	10803-111A2	101.75	0.60	2.78	1.79
thymus, adult, pool1	10027-101D9	178.15	1.39	0.70	1.99
thymus, fetal, pool1	10043-101F7	194.09	1.35	0.62	3.43
thyroid carcinoma cell line:KHM-5M	10776-110G2	45.07	1.06	1.33	0.66
thyroid carcinoma cell line:TCO-1	10783-110G9	62.16	1.12	1.40	0.42
thyroid, adult, pool1	10028-101E1	88.46	1.87	0.47	1.03
thyroid, fetal, donor1	10060-101H6	84.37	2.90	0.79	0.26
tongue epidermis (fungiform papillae), donor1	10288-104F9	86.23	0.00	0.00	0.00
tongue, adult	10203-103F5	73.03	0.93	2.56	0.93
tongue, fetal, donor1	10059-101H5	63.05	0.79	1.58	0.00
tonsil, adult, pool1	10047-101G2	138.54	1.20	0.20	0.40
trachea, adult, pool1	10029-101E2	61.92	0.98	0.33	0.08
trachea, fetal, donor1	10058-101H4	82.71	1.54	2.31	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	45.70	1.42	0.00	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	96.96	2.13	0.81	0.20
transitional-cell carcinoma cell line:JMSU1	10492-107B6	123.31	2.82	2.98	1.72
tridermal teratoma cell line:HGRT	10694-109G1	58.98	1.90	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	39.19	0.93	1.02	0.25
umbilical cord, fetal, donor1	10057-101H3	54.25	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	111.25	3.75	0.68	0.34
uterus, fetal, donor1	10055-101H1	87.03	0.51	2.05	0.00
vagina, adult	10204-103F6	41.36	1.29	0.65	0.00
vein, adult	10191-103E2	75.19	0.66	0.22	0.44
xeroderma pigentosum b cell line:XPL 17	10563-108A5	55.81	0.80	0.27	0.27